CRDF
Price
$2.88
Change
+$0.09 (+3.23%)
Updated
Jan 16, 04:59 PM (EDT)
Capitalization
187.94M
41 days until earnings call
Intraday BUY SELL Signals
TECX
Price
$18.76
Change
-$0.75 (-3.84%)
Updated
Jan 16, 04:59 PM (EDT)
Capitalization
365.15M
Intraday BUY SELL Signals
Interact to see
Advertisement

CRDF vs TECX

Header iconCRDF vs TECX Comparison
Open Charts CRDF vs TECXBanner chart's image
Cardiff Oncology
Price$2.88
Change+$0.09 (+3.23%)
Volume$23.37K
Capitalization187.94M
Tectonic Therapeutic
Price$18.76
Change-$0.75 (-3.84%)
Volume$4.27K
Capitalization365.15M
CRDF vs TECX Comparison Chart in %
CRDF
Daily Signal:
Gain/Loss:
TECX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRDF vs. TECX commentary
Jan 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDF is a Hold and TECX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 17, 2026
Stock price -- (CRDF: $2.79 vs. TECX: $19.51)
Brand notoriety: CRDF and TECX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRDF: 43% vs. TECX: 69%
Market capitalization -- CRDF: $187.94M vs. TECX: $365.15M
CRDF [@Biotechnology] is valued at $187.94M. TECX’s [@Biotechnology] market capitalization is $365.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDF’s FA Score shows that 0 FA rating(s) are green whileTECX’s FA Score has 0 green FA rating(s).

  • CRDF’s FA Score: 0 green, 5 red.
  • TECX’s FA Score: 0 green, 5 red.
According to our system of comparison, TECX is a better buy in the long-term than CRDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDF’s TA Score shows that 3 TA indicator(s) are bullish while TECX’s TA Score has 4 bullish TA indicator(s).

  • CRDF’s TA Score: 3 bullish, 6 bearish.
  • TECX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TECX is a better buy in the short-term than CRDF.

Price Growth

CRDF (@Biotechnology) experienced а -11.99% price change this week, while TECX (@Biotechnology) price change was -9.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.08%. For the same industry, the average monthly price growth was +4.20%, and the average quarterly price growth was +43.03%.

Reported Earning Dates

CRDF is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Biotechnology (-0.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECX($365M) has a higher market cap than CRDF($188M). CRDF YTD gains are higher at: -0.712 vs. TECX (-6.472). CRDF has higher annual earnings (EBITDA): -53.33M vs. TECX (-64.7M). TECX has more cash in the bank: 268M vs. CRDF (60.6M). CRDF has less debt than TECX: CRDF (1.01M) vs TECX (1.24M). CRDF has higher revenues than TECX: CRDF (501K) vs TECX (0).
CRDFTECXCRDF / TECX
Capitalization188M365M52%
EBITDA-53.33M-64.7M82%
Gain YTD-0.712-6.47211%
P/E RatioN/A4.59-
Revenue501K0-
Total Cash60.6M268M23%
Total Debt1.01M1.24M82%
FUNDAMENTALS RATINGS
CRDF vs TECX: Fundamental Ratings
CRDF
TECX
OUTLOOK RATING
1..100
7077
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
40
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9996
PRICE GROWTH RATING
1..100
5160
P/E GROWTH RATING
1..100
10072
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECX's Valuation (40) in the null industry is in the same range as CRDF (60). This means that TECX’s stock grew similarly to CRDF’s over the last 12 months.

TECX's Profit vs Risk Rating (100) in the null industry is in the same range as CRDF (100). This means that TECX’s stock grew similarly to CRDF’s over the last 12 months.

TECX's SMR Rating (96) in the null industry is in the same range as CRDF (99). This means that TECX’s stock grew similarly to CRDF’s over the last 12 months.

CRDF's Price Growth Rating (51) in the null industry is in the same range as TECX (60). This means that CRDF’s stock grew similarly to TECX’s over the last 12 months.

TECX's P/E Growth Rating (72) in the null industry is in the same range as CRDF (100). This means that TECX’s stock grew similarly to CRDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRDFTECX
RSI
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 10 days ago
85%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CRDF
Daily Signal:
Gain/Loss:
TECX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHPLF33.001.60
+5.10%
BHP Group Limited
ADDHY16.640.10
+0.59%
Addtech AB
CCTC0.65N/A
N/A
Catalyst Crew Technologies Corp.
CMGMF7.26N/A
N/A
Chemring Group Plc.
HONT128.75N/A
N/A
Honat Bancorp, Inc.

CRDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDF has been loosely correlated with FDMT. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDF jumps, then FDMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDF
1D Price
Change %
CRDF100%
-0.71%
FDMT - CRDF
41%
Loosely correlated
-13.13%
NRIX - CRDF
41%
Loosely correlated
-0.95%
CADL - CRDF
40%
Loosely correlated
-4.35%
ORMP - CRDF
39%
Loosely correlated
+1.37%
SYRE - CRDF
39%
Loosely correlated
-0.21%
More

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with IGC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then IGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
-0.81%
IGC - TECX
49%
Loosely correlated
-3.14%
SRPT - TECX
35%
Loosely correlated
-6.54%
CRDF - TECX
35%
Loosely correlated
-0.71%
IMNM - TECX
35%
Loosely correlated
+10.07%
ATHE - TECX
35%
Loosely correlated
-0.37%
More